Core Insights - Valmont Industries, Inc. (VMI) reported fourth-quarter 2025 adjusted earnings of $4.92 per share, a 28.1% increase from $3.84 in the same quarter last year, but missed the Zacks Consensus Estimate of $4.95 [1] - The company's revenues for the fourth quarter were $1,038.3 million, reflecting a 0.1% year-over-year increase, yet fell short of the Zacks Consensus Estimate of $1,046.9 million [1] Segment Review - Fourth-quarter revenues in the infrastructure segment increased by 7.2% year over year to $819 million, missing the estimate of $825.8 million, driven by strong utility sales growth and steady sales in other North America infrastructure products [2] - Utility sales rose by 21%, supported by favorable pricing and higher volumes, although a significant decline in solar sales and softness in the Asia-Pacific market offset this growth [3] - Agriculture revenues decreased by 19.9% year over year to $222.7 million, but outperformed the estimate of $213.6 million, primarily due to softer demand for irrigation equipment and ongoing macroeconomic challenges [4] Financials - The company ended the quarter with cash and cash equivalents of $187.1 million, and cash provided by operating activities was $456.5 million, down approximately 20% year over year [5] - VMI returned $85.6 million to shareholders through dividends and share repurchases during the quarter and invested $40.8 million in capital expenditures for growth initiatives [5] 2026 Outlook - VMI provided guidance for full-year 2026, anticipating net sales of approximately $4.2-$4.4 billion, with infrastructure-segment revenues of about $3.25-$3.4 billion and agriculture-segment revenues of around $0.95-$1 billion [6] - The earnings per share outlook is set in the range of $20.5 to $23.50, with capital expenditures expected to be between $170-$200 million and an effective tax rate of approximately 26% [6] Stock Performance - VMI shares have increased by 20.8% over the past year, compared to the industry's growth of 25.0% [7]

Core Insights - MKS Instruments Inc. reported fourth-quarter results that exceeded analyst expectations, but shares declined over 10% in after-hours trading [1] - The company posted adjusted earnings of $2.47 per share, surpassing the consensus estimate of $2.30, and revenue reached $1.03 billion, beating expectations of $995.32 million, marking a 10.5% year-over-year increase [1] Segment Performance - The Semiconductor segment led performance with revenue of $435 million, reflecting an 8.8% year-over-year increase [2] - Electronics & Packaging revenue rose 19.3% to $303 million, while Specialty Industrial revenue increased by 5% to $295 million [2] Future Guidance - For the first quarter of 2026, MKS guided revenue of $1.04 billion, plus or minus $40 million, above the consensus estimate of $1.01 billion [2] - The company forecast adjusted earnings of $2.00 per share, plus or minus $0.28, exceeding expectations of $1.87 per share [2]

Core Insights - MKS reported $1.03 billion in revenue for Q4 2025, a 10.5% year-over-year increase, with an EPS of $2.47 compared to $2.15 a year ago, indicating strong financial performance [1] - The revenue exceeded the Zacks Consensus Estimate of $1.02 billion by 1.2%, while the EPS fell short of the consensus estimate of $2.51 by 1.71% [1] Revenue Breakdown - Semiconductor segment generated $435 million, surpassing the average estimate of $421.37 million, reflecting an 8.8% year-over-year increase [4] - Electronics and Packaging segment reported $303 million, exceeding the estimated $298.92 million, with a 19.3% year-over-year growth [4] - Specialty Industrial segment achieved $295 million, above the average estimate of $285.23 million, marking a 5% year-over-year increase [4] - Products segment recorded $907 million, exceeding the estimate of $866.43 million, representing a 10.1% year-over-year growth [4] - Services segment reported $126 million, slightly below the estimate of $126.87 million, with a year-over-year increase of 13.5% [4] Stock Performance - MKS shares have returned +27.8% over the past month, significantly outperforming the Zacks S&P 500 composite, which saw a -1.4% change [3] - The stock currently holds a Zacks Rank 1 (Strong Buy), suggesting potential for continued outperformance in the near term [3]

Health insurance company Lemonade Inc (NYSE:LMND) is gearing up for its fourth-quarter report, due out before the open on Thursday, Feb. 19. Per Zacks Research, analysts anticipate losses of 41 cents per share on revenue of $216 million, a 2.4% and 45.6% improvement, respectively, from the same quarter a year ago. On the charts, Lemonade stock pulled back sharply after its Jan. 22 more than four-year high of $99.90, though the stock appears to have found support at the $60 level and 180-day moving average. ...

Group 1: Stock Performance and Market Sentiment - Transocean Ltd shares are experiencing a decline as investors lock in gains after reaching a 52-week high, with the energy sector currently underperforming, down approximately 1.5% [1] - The stock is trading 6.8% below its 20-day simple moving average (SMA) and 4.5% below its 100-day SMA, indicating a bearish short-term trend [4] - Over the past 12 months, shares have increased by 72.95%, reflecting strong long-term performance [4] - At the time of publication, Transocean shares were down 6.12% at $6.15 [7] Group 2: Contract Awards and Backlog - Transocean secured significant contract fixtures for two harsh environment semisubmersibles in Norway, enhancing its backlog visibility [2] - The Transocean Encourage received a seven-well contract extension, estimated to provide around $152 million in backlog, while the Transocean Enabler has two one-well options exercised, contributing an additional $32 million [2] - These contracts are set to commence in the first quarter of 2027, extending operational commitments through December 2027 [3] Group 3: Technical Indicators and Analyst Consensus - The Relative Strength Index (RSI) is at a neutral level, indicating the stock is neither overbought nor oversold, while the MACD is below its signal line, suggesting bearish pressure [5] - The stock carries a Hold Rating with an average price target of $6.44, with recent analyst actions including a Buy rating from BTIG, raising the target to $10.00 [7][8] - Key resistance is identified at $6.50 and key support at $5.50, with EPS estimates at 8 cents and revenue estimates at $1.04 billion [8]

Core Insights - Medtronic reported $9.02 billion in revenue for the quarter ended January 2026, marking an 8.7% year-over-year increase and a surprise of +1.35% over the Zacks Consensus Estimate of $8.9 billion [1] - The earnings per share (EPS) for the same period was $1.36, slightly down from $1.39 a year ago, with an EPS surprise of +2.07% compared to the consensus estimate of $1.33 [1] Revenue Breakdown - U.S. Revenue: $4.49 billion, a 6% year-over-year increase, but below the average estimate of $4.59 billion [4] - International Revenue: $4.52 billion, exceeding the average estimate of $4.3 billion [4] - Cardiovascular Revenue: $3.46 billion, a 13.8% year-over-year increase, surpassing the average estimate of $3.39 billion [4] - Neuroscience Revenue: $2.56 billion, a 4.1% year-over-year increase, slightly below the average estimate of $2.58 billion [4] - Medical Surgical Revenue: $2.17 billion, a 4.9% year-over-year increase, exceeding the average estimate of $2.14 billion [4] - Diabetes Revenue: $796 million, a 14.7% year-over-year increase, surpassing the average estimate of $773.73 million [4] - Cardiac Rhythm & Heart Failure Revenue: $1.86 billion, a significant 20.1% year-over-year increase, exceeding the average estimate of $1.8 billion [4] Stock Performance - Medtronic shares have returned +2.8% over the past month, contrasting with a -1.4% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]

Group 1 - Labcorp Holdings reported revenue of $3.52 billion for the quarter ended December 2025, reflecting a 5.6% increase year-over-year [1] - The company's EPS for the quarter was $4.07, up from $3.45 in the same quarter last year, with an EPS surprise of +2.98% compared to the consensus estimate of $3.95 [1] - The reported revenue was slightly below the Zacks Consensus Estimate of $3.55 billion, resulting in a revenue surprise of -0.97% [1] Group 2 - Key metrics indicate that Labcorp's shares have returned +4.3% over the past month, outperforming the Zacks S&P 500 composite, which declined by -1.4% [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3] Group 3 - The net book-to-bill ratio for Labcorp was reported at 1.1%, matching the average estimate based on two analysts [4] - Revenues from Biopharma Laboratory Services were $793 million, slightly above the average estimate of $791.05 million, representing a year-over-year change of +3.4% [4] - Revenues from Diagnostics Laboratories were $2.73 billion, below the average estimate of $2.77 billion, with a year-over-year change of +5.5% [4] - Adjusted Operating Income for Diagnostics Laboratories was $419.2 million, slightly below the average estimate of $423.58 million [4] - Adjusted Operating Income for Biopharma Laboratory Services was $136.1 million, exceeding the average estimate of $130.1 million [4] - Unallocated corporate expenses were reported at -$67.6 million, better than the average estimate of -$69.13 million [4]

Core Insights - Lincoln Educational Services is expected to report Q4 2025 earnings of $0.42 per share on February 23, 2026 [2] - The stock price opened at $28.90, with a market cap of $913.82 million and a P/E ratio of 64.22 [3] Financial Performance - The company has a 50-day moving average of $25.15 and a 200-day moving average of $22.44 [3] - The stock has fluctuated between a 12-month low of $14.10 and a high of $30.21 [3] Insider Activity - Director Kevin M. Carney sold 13,866 shares at an average price of $22.18, resulting in a total transaction of approximately $307,547.88, reducing his ownership by 35.84% [4] Institutional Holdings - 72.23% of Lincoln Educational Services' stock is owned by institutional investors [5] - Notable institutional activity includes MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increasing its stake by 3.7% and Intech Investment Management LLC by 6.5% [5][6] Analyst Ratings - Wall Street Zen upgraded the stock from "hold" to "buy" [7] - B. Riley Financial raised the price target from $27.00 to $33.00, maintaining a "buy" rating [7][8] - The consensus rating is "Buy" with a price target of $29.00 [8] Company Overview - Lincoln Educational Services provides career-focused post-secondary vocational education in the U.S. under the Lincoln Tech and Lincoln Culinary Institute brands [9] - The company offers programs in automotive technology, skilled trades, health sciences, information technology, culinary arts, and public safety [10]

Core Viewpoint - Occidental Petroleum is expected to report its fourth-quarter and full-year earnings on February 18, which could act as a catalyst for its stock price [1] Group 1: Recent Performance - In the third quarter, Occidental Petroleum reported strong financial results, with oil and gas output reaching nearly 1.5 million barrels of oil equivalent per day, exceeding guidance [4] - The company achieved an adjusted net income of $0.64 per share, surpassing analysts' consensus estimate by $0.12 [4] - Higher oil and gas prices contributed to the strong performance, with oil sold at an average of $64.78 per barrel, a 2% increase from the previous quarter, and natural gas prices up 11% [5] Group 2: Market Reactions and Expectations - Despite strong quarterly results, Occidental's stock price showed minimal movement post-earnings, dipping initially before rising over 10% in January due to oil price increases and strategic progress [7] - Analysts predict a challenging fourth quarter for Occidental, with oil prices declining by about 10%, leading to a consensus earnings estimate of only $0.19 per share [9] - Historically, Occidental has beaten analysts' estimates for three consecutive quarters, suggesting the potential for a positive surprise in the upcoming report [10] Group 3: External Factors Influencing Stock Price - Changes in oil prices are currently more significant for Occidental's stock than earnings reports, with potential supply disruptions related to Iran possibly driving crude prices higher [11] - Military action against Iran could lead to a surge in crude prices, positively impacting Occidental's stock [11] - Investors may consider purchasing Occidental shares before the earnings report if they anticipate a spike in oil prices [12]

Group 1: Institutional Holdings - Richardson Financial Services Inc. increased its holdings in OSI Systems by 58.2% during Q3, now owning 144 shares valued at $36,000 after acquiring 53 additional shares [1] - Nisa Investment Advisors LLC raised its position by 28.6% in Q3, now holding 256 shares worth $64,000 after acquiring 57 shares [1] - Bessemer Group Inc. boosted its position by 78.7% in Q2, now owning 134 shares valued at $30,000 after acquiring 59 shares [1] - Arizona State Retirement System raised its stake by 1.5% in Q3, now owning 4,711 shares valued at $1,174,000 after acquiring 71 shares [1] - Yousif Capital Management LLC increased its holdings by 1.3% in Q2, now owning 5,827 shares valued at $1,310,000 after purchasing 77 shares [1] - 89.21% of OSI Systems stock is currently owned by institutional investors [1] Group 2: Analyst Ratings and Price Targets - UBS Group set a price objective of $292.00 for OSI Systems [2] - Roth Mkm raised their price target from $292.00 to $295.00, maintaining a "buy" rating [2] - JPMorgan Chase & Co. lifted their price objective from $255.00 to $262.00, giving a "neutral" rating [2] - Bank of America increased their price objective from $265.00 to $315.00, maintaining a "buy" rating [2] - Weiss Ratings upgraded the stock from a "buy (b)" to a "buy (a-)" rating [2] - The average rating for the stock is "Buy" with an average price target of $282.00 [2] Group 3: Financial Performance - OSI Systems reported an EPS of $2.58 for the last quarter, beating estimates of $2.52 by $0.06 [4] - The company had revenue of $464.06 million, exceeding expectations of $449.51 million, representing a 10.5% increase compared to the same quarter last year [4] - The return on equity was 18.58% with a net margin of 8.52% [4] - Analysts forecast an EPS of 9.22 for the current fiscal year [4] Group 4: Stock Performance and Metrics - OSI Systems stock opened at $268.61, with a 1-year low of $153.40 and a high of $294.93 [3] - The stock has a market capitalization of $4.42 billion, a price-to-earnings ratio of 30.42, and a PEG ratio of 2.16 [3] - The company has a debt-to-equity ratio of 1.18, a current ratio of 3.15, and a quick ratio of 2.31 [3] Group 5: Insider Activity - Director Deepak Chopra sold 20,000 shares at an average price of $250.91, totaling $5,018,200, representing a 6.82% decrease in their position [5] - Following the sale, the director owns 273,044 shares valued at approximately $68.51 million [5] - Insiders own 4.30% of the stock [5]